{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:52:07Z","timestamp":1785275527514,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1599,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.virol.2008.11.045","type":"journal-article","created":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T09:22:57Z","timestamp":1230888177000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Risks associated with vaccinia virus in the laboratory"],"prefix":"10.1016","volume":"385","author":[{"given":"Adam","family":"MacNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary G.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger K.","family":"Damon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2008.11.045_bib1","unstructured":"Chosewood, C.L., Wilson, D.E. (Eds.), 2007. Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition., 5 ed. US Government Printing Office, Washington D.C."},{"issue":"15","key":"10.1016\/j.virol.2008.11.045_bib2","first-page":"401","article-title":"Laboratory-acquired vaccinia exposures and infections\u2014United States, 2005\u20132007","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.virol.2008.11.045_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virol.2008.11.045_bib4","unstructured":"ATCC; 2008 www.atcc.org."},{"issue":"8","key":"10.1016\/j.virol.2008.11.045_bib5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/428731","article-title":"Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program","volume":"40","author":"Baggs","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2008.11.045_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/infdis\/136.3.453","article-title":"The origins of vaccinia virus","volume":"136","author":"Baxby","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2008.11.045_bib7","series-title":"Recombinant Poxviruses.","author":"Binns","year":"1992"},{"issue":"6040","key":"10.1016\/j.virol.2008.11.045_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.virol.2008.11.045_bib9","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January\u2013October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"issue":"RR\u20131","key":"10.1016\/j.virol.2008.11.045_bib10","first-page":"1","article-title":"Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions","volume":"55","author":"Casey","year":"2006","journal-title":"MMWR Recomm. Rep."},{"issue":"8","key":"10.1016\/j.virol.2008.11.045_bib11","first-page":"207","article-title":"Notice to readers: newly licensed smallpox vaccine to replace old smallpox vaccine","volume":"57","year":"2008","journal-title":"MMWR"},{"issue":"12","key":"10.1016\/j.virol.2008.11.045_bib12","first-page":"3403","article-title":"Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques","volume":"5","author":"Chakrabarti","year":"1985","journal-title":"Mol. Cell. Biol."},{"issue":"RR\u20134","key":"10.1016\/j.virol.2008.11.045_bib13","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recomm. Rep."},{"issue":"3","key":"10.1016\/j.virol.2008.11.045_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.virol.2008.11.045_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.virol.2008.11.045_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2008.11.045_bib17","first-page":"73","article-title":"Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire","volume":"40","author":"Jezek","year":"1988","journal-title":"Trop. Geogr. Med."},{"issue":"6054","key":"10.1016\/j.virol.2008.11.045_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/319543a0","article-title":"Accidental human vaccination with vaccinia virus expressing nucleoprotein gene","volume":"319","author":"Jones","year":"1986","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.virol.2008.11.045_bib19","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/jvi.66.5.2617-2630.1992","article-title":"Molecular attenuation of vaccinia virus: mutant generation and animal characterization","volume":"66","author":"Lee","year":"1992","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2008.11.045_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3201\/eid1201.051126","article-title":"Ocular vaccinia infection in laboratory worker, Philadelphia, 2004","volume":"12","author":"Lewis","year":"2006","journal-title":"Emerg. Infect. Dis."},{"issue":"15","key":"10.1016\/j.virol.2008.11.045_bib21","first-page":"134","article-title":"Laboratory-acquired vaccinia infection","volume":"29","author":"Loeb","year":"2003","journal-title":"Can. Commun. Dis. Rep."},{"issue":"3","key":"10.1016\/j.virol.2008.11.045_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/jvi.49.3.857-864.1984","article-title":"General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes","volume":"49","author":"Mackett","year":"1984","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2008.11.045_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1523-1747.2003.12074.x","article-title":"Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct","volume":"120","author":"Mempel","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"21","key":"10.1016\/j.virol.2008.11.045_bib24","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety","volume":"93","author":"Moss","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.virol.2008.11.045_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3201\/eid0906.020732","article-title":"Accidental infection of laboratory worker with vaccinia virus","volume":"9","author":"Moussatche","year":"2003","journal-title":"Emerg. Infect. Dis."},{"issue":"8764","key":"10.1016\/j.virol.2008.11.045_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0140-6736(91)91093-A","article-title":"Accidental infection of laboratory worker with recombinant vaccinia virus","volume":"338","author":"Openshaw","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.virol.2008.11.045_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vaccine.2006.07.022","article-title":"Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine","volume":"25","author":"Phelps","year":"2007","journal-title":"Vaccine"},{"issue":"RR\u201310","key":"10.1016\/j.virol.2008.11.045_bib28","first-page":"1","article-title":"Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001","volume":"50","author":"Rotz","year":"2001","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.virol.2008.11.045_bib29","series-title":"\"Orthopoxviruses Pathogenic for Humans\"","author":"Shchelkunov","year":"2005"},{"issue":"22","key":"10.1016\/j.virol.2008.11.045_bib30","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.virol.2008.11.045_bib31","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1128\/JVI.00945-06","article-title":"Genome of horsepox virus","volume":"80","author":"Tulman","year":"2006","journal-title":"J. Virol."},{"issue":"RR\u20137","key":"10.1016\/j.virol.2008.11.045_bib32","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm. Rep."},{"issue":"3","key":"10.1016\/j.virol.2008.11.045_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1386-6532(03)00118-5","article-title":"Laboratory-acquired vaccinia infection","volume":"29","author":"Wlodaver","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virol.2008.11.045_bib34","series-title":"\"Strains of Human Viruses\"","first-page":"125","article-title":"Vaccinia virus","author":"Wokatsch","year":"1972"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208007976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208007976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:56:16Z","timestamp":1758585376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682208007976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0042682208007976"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2008.11.045","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks associated with vaccinia virus in the laboratory","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2008.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}